Woodline Partners’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Woodline Partners's LLY Position: Q2 2026 in Review
Woodline Partners increased its Eli Lilly (LLY) stake by 6.2% in Q2 2026, buying an estimated $14.7M and bringing the position to 244,861 shares worth $294M. The position accounts for 0.91% of the portfolio, ranked #11.
Woodline Partners first reported a position in LLY in Q4 2019 and has held it in 27 quarters since. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Woodline Partners held 244,861 shares of Eli Lilly worth $294M as of Q2 2026.
- Woodline Partners bought 14,387 Eli Lilly shares in Q2 2026, an estimated $14.7M.
- Eli Lilly made up 0.91% of Woodline Partners's portfolio in Q2 2026, its #11 holding.
- Woodline Partners first reported a position in Eli Lilly in Q4 2019 and has held it in 27 quarters since.
- 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Woodline Partners's 13F filing for Q2 2026, filed 14 Aug 2026.